On May 13, 2026, The 92nd PharmChina was kicked off at the National Exhibition and Convention Center in Shanghai. As a leading professional trade and exchange exhibition platform for the pharmaceutical and healthcare industry, more than thousands of pharmaceutical companies and 100,000 professionals were gathered at this fair. Lee’s Pharmaceutical Holdings Ltd. (Lee’s Pharm or […]
The award ceremony for the 11th PEF Training Excellence Award (Premio Eccellenza Formazione), promoted by AIF (Associazione Italiana Formatori) under the Italian Association of Educational Trainers, was successfully held in recent days. The Matrix Series of China-Europe International Medical Education Programs, sponsored by Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950）, […]
Lee’s Pharmaceutical Holdings Limited (referred to as “Lee’s Pharm” or “the Group”, stock code: 00950) and Shaohe Biotechnology Co., Ltd., Guangdong (hereinafter referred to as “Shaohe Biotech”) announced a strategic partnership to jointly build a new ecosystem for the probiotic industry. This collaboration aims to translate probiotic research from the laboratory to public health applications, […]
The 2nd Sino-European Brain-Heart Alliance Academic Conference has been successfully held in Shanghai during June 13–14, 2025. The conference was jointly hosted by the Chinese Neuroscience Society’s Basic and Clinical Psychiatry Subcommittee, the University of Mediterranean Free State in Italy, and the University of Padua in Italy. The event brought together the top medical experts […]
On 8th June 2025, Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950) announced a significant milestone through its wholly-owned subsidiary Zhaoke Pharmaceutical (Hefei) Co., Ltd. (“Zhaoke-Hefei”)— the launch of the new production line of prefilled filling with isolator. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
The Pulmonary Hypertension Summit Forum – Henan Province, part of a series of the ⟨Life and Health China Tour 2025⟩, was successfully held on May 24 at the Hilton Hotel in Zhengzhou. The forum gathered cutting-edge research on pulmonary hypertension, exploring topics such as disease mechanisms, targeted drug development, and multidisciplinary treatment model innovations, aiming […]
February 26, 2025, the “Thematic Seminar on Biotechnology Innovation and Translation Project”, organized by The Hong Kong Bio-Med Innotech Association (HKBMIA), was successfully held. The seminar aims to share a series of achievements of the project and conduct presentations and discussions on the industry’s hotspots, to explore the innovations of the biopharmaceutical industry and the […]
Hong Kong, December 20, 2024 – The “STEM Experience Program for Secondary Students——Kanya Lee Scholarship Recognition Ceremony 2024” was successfully held in Hong Kong Disneyland Hotel. ดาวน์โหลดข่าวฉบับเต็ม (PDF) ที่มา: Lee’s Pharmaceutical Holdings – News & Media
Recently, the list of the 2024 “New Force Enterprises” of Hefei High-tech Zone was announced. Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke- Hefei”), a subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” or the “Group”, stock code: 00950), was successfully recognized as “New Force Enterprise” for its outstanding performance in technological innovation, industrial influence, and new […]
Recently, the Hefei Science and Technology Bureau of Anhui Province announced the proposed list of “New Technologies, New Products, and New Models in Hefei for 2024.” After rounds of selection, the Treprostinil Injection, a product of Zhaoke Pharmaceutical (Hefei) Company Limited (“Zhaoke Hefei”), which is a wholly-owned subsidiary of Lee’s Pharmaceutical Holdings Limited (“Lee’s Pharm” […]
Thai 
English